Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171641 | SCV000050771 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001084908 | SCV000554481 | benign | Brugada syndrome 8 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000171641 | SCV000729881 | likely benign | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24607718, 26230511, 26704558, 25642760, 28831623, 23861362, 30821013) |
Ambry Genetics | RCV000619356 | SCV000737745 | likely benign | Cardiovascular phenotype | 2016-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV000171641 | SCV001744639 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000171641 | SCV001973514 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000171641 | SCV001979598 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535165 | SCV004729561 | likely benign | HCN4-related disorder | 2019-05-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |